IPSO Surgical Practice Guidelines
Download
Authors
Simone de Campos Vieira Abib1, Chan Hon Chui2, Sharon Cox3, Abdelhafeez H Abdelhafeez4, Israel Fernandez-Pineda5, Ahmed Elgendy6, Jonathan Karpelowsky7, Pablo Lobos8, Marc Wijnen9, Jörg Fuchs10, Andrea Hayes11 and Justin T Gerstle12
- Pediatric Oncology Institute, GRAACC, Federal University of São Paulo, Rua Pedro de Toledo, 572 – Vila Clementino, São Paulo, SP 04021-001, Brazil
- Surgery Centre for Children, Mount Elizabeth Medical Centre, 3 Mount Elizabeth, 228510, Singapore
- Division of Paediatric Surgery, Red Cross War Memorial Children’s Hospital, University of Cape Town, Cape Town, South Africa
- Department of Surgery, St Jude Research Hospital 262 Danny Thomas Place. MS133, Memphis, TN 38105, USA
- Department of Pediatric Surgery, Virgen del Rocio Children’s Hospital, Av Manuel Siurot S/NN, Sevilla 41013, Spain
- Surgical Oncology Unit, Faculty of Medicine, Tanta University, Elgiesh Street, 31111, Tanta, Gharbeya, Egypt
- Department of Paediatric Surgery, Children’s Hospital at Westmead, Westmead NSW 2145, Australia
- Pediatric Surgery Division, Hospital Italiano de Buenos Aires, Andrés Lamas 812, Buenos Aires 1406, Argentina
- Department of Surgery, Princess Maxima Center for Pediatric Oncology, Huispostnummer KE 01.129.2, Postbus 85090, Utretcht 3508AB, The Netherlands
- Department of Pediatric Surgery and Pediatric Urology, University of Tuebingen, Hoppe-Seyler-Str. 3, Tübingen 72076, Germany
- Department of Surgery, Howard University Hospital, 1851 9th Street NW, 4th Floor, Washington, DC 20059, USA
- Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Abstract
Most children with tumors will require one or more surgical interventions as part of the care and treatment, including making a diagnosis, obtaining adequate venous access, performing a surgical resection for solid tumors (with staging and reconstruction), performing procedures for cancer prevention and its late effects, and managing complications of treatment; all with the goal of improving survival and quality of life. It is important for surgeons to adhere to sound pediatric surgical oncology principles, as they are closely associated with improved local control and survival. Unfortunately, there is a significant disparity in survival rates in low and middle income countries, when compared to those from high income countries.
The International Society of Paediatric Surgical Oncology (IPSO) is the leading organization that deals with pediatric surgical oncology worldwide. This organization allows experts in the field from around the globe to gather and address the surgical needs of children with cancer. IPSO has been invited to contribute surgical guidance as part of the World Health Organization Initiative for Childhood Cancer. One of our goals is to provide surgical guidance for different scenarios, including those experienced in High- (HICs) and Low- and Middle- Income Countries (LMICs). With this in mind, the following guidelines have been developed by authors from both HICs and LMICs. These have been further validated by experts with the aim of providing evidence-based information for surgeons who care for children with cancer.
We hope that this initiative will benefit children worldwide in the best way possible.
Simone Abib, IPSO President
Justin T Gerstle, IPSO Education Committee Chair
Chan Hon Chui, IPSO Secretary
Keywords: paediatric oncology surgery, paediatric cancer, surgery, children
Disclaimer
The document, IPSO Surgical Practice Guidelines, and the information it contains are for authorised use by surgeons. IPSO cannot accept any liability and responsibility for any claims, loss or damage arising from the use of this document and its contents.
Contents Overview only
IPSO SURGICAL PRACTICE GUIDELINES | 1 | ||
Introduction | 1 | ||
Disclaimer | 2 | ||
Contributing Authors | 9 | ||
1. Role of Surgery in Paediatric Cancer Diagnosis | 9 | ||
2. Management of Lymph Node Enlargement in Children | 9 | ||
3. Venous Access for the Paediatric Cancer Patient | 9 | ||
4. Neuroblastoma | 10 | ||
5. Wilms Tumour | 11 | ||
6. Rhabdomyosarcoma and Non-Rhabdomyosarcoma Soft Tissue Sarcoma | 11 | ||
7. Osteosarcoma and Ewing Sarcoma | 11 | ||
8. Liver Tumours | 11 | ||
9. Germ Cell Tumours | 12 | ||
10. Thoracic Tumours | 13 | ||
11. Pulmonary Metastasis | 13 | ||
12. Surgical Strategies in Pelvic Tumours | 13 | ||
13. Rare Tumours | 14 | ||
14. Surgery for Lymphoma | 15 | ||
15. MIS in Paediatric Oncology | 15 | ||
16. Surgical Emergencies in Paediatric Surgical Oncology | 16 | ||
17. Fertility Preservation | 17 | ||
18. Paediatric Surgical Oncology and Palliative Care | 18 | ||
ROLE OF SURGERY IN PAEDIATRIC CANCER DIAGNOSIS | 19 | ||
Introduction | 19 | ||
Abdominal Mass | 19 | ||
Scrotal Mass | 22 | ||
Thoracic Mass | 23 | ||
Neck Mass | 23 | ||
Extremity Mass | 28 | ||
Tips and Pitfalls in the Diagnosis of Paediatric Cancer | 28 | ||
MANAGEMENT OF LYMPH NODE ENLARGEMENT IN CHILDREN | 33 | ||
Preoperative: Evaluation, Images, Special Needs and Biopsy Need | 33 | ||
Surgical Goals | 34 | ||
Pitfalls | 34 | ||
Surgery | 35 | ||
Complications | 35 | ||
Conclusions | 35 | ||
VENOUS ACCESS FOR THE PAEDIATRIC CANCER PATIENT | 36 | ||
Devices Available | 36 | ||
Surgical Goals | 36 | ||
Preoperative Evaluation, Images and Special Needs | 36 | ||
Surgery | 37 | ||
Postoperative Period | 39 | ||
Complications | 39 | ||
Tips and Pitfalls | 40 | ||
NEUROBLASTOMA | 42 | ||
Epidemiology | 42 | ||
Preoperative Evaluation | 42 | ||
Indications for Surgery | 44 | ||
Perioperative Management | 45 | ||
Surgical Goals | 45 | ||
Postoperative Considerations | 45 | ||
Complications | 47 | ||
Tips and Pitfalls | 47 | ||
WILMS TUMOUR | 55 | ||
Evaluation | 55 | ||
Indications and Principles of Biopsy | 55 | ||
Perioperative Management | 56 | ||
Surgery | 57 | ||
Tips, Pitfalls and Complications | 59 | ||
Postoperative Considerations | 59 | ||
Prognosis, Prognostics and Follow-up | 59 | ||
RHABDOMYOSARCOMA AND NON-RHABDOMYOSARCOMA SOFT-TISSUE SARCOMA | 62 | ||
Introduction | 62 | ||
Rhabdomyosarcoma | 63 | ||
Treatment of RMS | 63 | ||
Guidelines for Surgery for RMS | 65 | ||
Surgical Guidelines for Various Sites | 66 | ||
Complications of Surgery | 67 | ||
NON-RHABDOMYOSARCOMA SOFT-TISSUE SARCOMA | 68 | ||
Surgical Principles | 68 | ||
Surgical Considerations | 69 | ||
OSTEOSARCOMA AND EWING SARCOMA | 71 | ||
Epidemiology | 71 | ||
Preoperative Evaluation, Images, Special Needs, Biopsy and Indications for Surgery | 71 | ||
Surgical Goals | 71 | ||
Perioperative Management | 72 | ||
Surgical Approach | 72 | ||
Complications | 74 | ||
Postoperative Considerations | 75 | ||
Tips | 76 | ||
Pitfalls | 76 | ||
LIVER TUMOURS: HEPATOBLASTOMA | 80 | ||
Evaluation | 80 | ||
Indications and Principles of Biopsy versus Resection at Diagnosis | 81 | ||
Role and Timing of Multimodality Therapy | 82 | ||
Surgical Management | 82 | ||
Key Steps of the Surgical Procedure: Hepatectomy | 84 | ||
Types of Liver Resections | 86 | ||
Post-operative Management | 87 | ||
Pitfalls, and Potential Surgical Complications | 87 | ||
Other Surgical Considerations | 88 | ||
Outcome | 89 | ||
LIVER TUMOURS: PAEDIATRIC HEPATOCELLULAR CARCINOMA | 92 | ||
Evaluation | 92 | ||
Treatments | 94 | ||
Surgical Procedures in Paediatric HCC | 94 | ||
Chemotherapy | 95 | ||
Ablative Therapies | 97 | ||
Outcome | 98 | ||
EXTRACRANIAL GERM CELL TUMOUR | 101 | ||
Introduction | 101 | ||
Sacrococcygeal Germ Cell Tumour | 101 | ||
Mediastinal Germ Cell Tumour | 102 | ||
Abdominal and Retroperitoneal Germ Cell Tumour | 103 | ||
Head and Neck Germ Cell Tumour | 104 | ||
Genitourinary Germ Cell Tumour | 105 | ||
Gonadal Germ Cell Tumour | 105 | ||
Testicular Tumours | 108 | ||
THORACIC TUMOURS | 114 | ||
Background | 114 | ||
Tumours of the Chest Wall | 114 | ||
Mediastinal Tumours | 117 | ||
Primary Pulmonary Tumours | 121 | ||
Pleuropulmonary Blastoma (PPB) | 121 | ||
Pulmonary Carcinoid Tumours | 123 | ||
Inflammatory Myofibroblastic Tumour | 124 | ||
SURGICAL APPROACH TO PULMONARY METASTASIS IN CHILDREN | 129 | ||
Introduction | 129 | ||
Surgical Goals | 129 | ||
Work-Up | 129 | ||
Surgical Technique | 129 | ||
Tumour Specific Management | 130 | ||
Complications | 132 | ||
Conclusion | 133 | ||
SURGICAL STRATEGIES IN PELVIC TUMOURS | 138 | ||
Evaluation | 138 | ||
Workup | 139 | ||
Indications and Principles of Biopsy | 140 | ||
Perioperative Management | 140 | ||
Surgery | 141 | ||
Key Steps | 143 | ||
Tips, Pitfalls and Complications | 144 | ||
Postoperative Considerations | 145 | ||
Prognosis and Follow-up | 145 | ||
RARE TUMOURS | 148 | ||
Introduction | 148 | ||
Pancreatic Tumours | 150 | ||
Background | 150 | ||
Solid-Cystic Papillary Tumour (SCPT) of The Pancreas | 150 | ||
Pancreatoblastoma (PBL) | 152 | ||
Neuroendocrine Tumours (NET) | 154 | ||
Pseudopapillary Tumours | 155 | ||
Pancreatic Carcinoma | 155 | ||
Pleuropulmonary Blastoma | 159 | ||
Evaluation | 159 | ||
Perioperative Management | 160 | ||
Advanced Stages and Relapsed Disease | 161 | ||
Postoperative Considerations | 161 | ||
Prognosis, Prognostics and Follow-up | 161 | ||
Phaeochromocytoma and Paraganglioma | 163 | ||
Introduction | 163 | ||
Diagnostic Investigations | 164 | ||
Assessment of Patients on Admission | 166 | ||
Surgical Technique | 166 | ||
Post-operative Management | 168 | ||
Postoperative Outcome & Follow-up | 168 | ||
Non-Germ Cell Gonadal Tumours | 172 | ||
Evaluation | 172 | ||
Perioperative Management | 173 | ||
Prognosis, Prognostics and Follow-up | 176 | ||
Colorectal Carcinoma | 178 | ||
Incidence | 178 | ||
Clinical Presentation | 178 | ||
Diagnosis | 178 | ||
Management | 178 | ||
Prognosis | 179 | ||
Adrenocortical Tumours | 180 | ||
Background | 180 | ||
Epidemiology | 180 | ||
Clinical Presentation | 180 | ||
Workup | 181 | ||
Imaging | 181 | ||
Additional Assessments | 182 | ||
Diagnosis | 182 | ||
Surgery | 182 | ||
Metastases | 183 | ||
Preoperative Considerations | 183 | ||
Role and Timing of Multimodality Therapy | 183 | ||
Staging | 183 | ||
Postoperative Considerations | 183 | ||
Treatment for Malignant ACT | 184 | ||
Follow-up | 184 | ||
Gastrointestinal Stromal Tumours (GIST) | 186 | ||
Epidemiology, Biology and Clinical Aspects | 186 | ||
Treatment | 186 | ||
Melanoma | 189 | ||
Evaluation | 189 | ||
Pre-Operative Management | 190 | ||
Surgical Guidelines | 190 | ||
Postoperative Management | 190 | ||
Salivary Gland Tumours | 192 | ||
Evaluation | 192 | ||
Indications and Principles of Biopsy | 193 | ||
Perioperative Management | 193 | ||
Surgery | 193 | ||
Postoperative Considerations | 193 | ||
Prognosis and Follow-up | 194 | ||
Neuroendocrine Tumours of the GI Tract | 196 | ||
Evaluation | 196 | ||
Perioperative Management | 197 | ||
Surgery | 198 | ||
Postoperative Considerations | 199 | ||
Prognosis, Prognostics and Follow-up | 199 | ||
SURGERY FOR LYMPHOMA | 202 | ||
Introduction | 202 | ||
Surgical Goals | 202 | ||
Preoperative: Evaluation, Images, Special Needs, Biopsy Need? | 202 | ||
Special Considerations for Lymph Node Sampling | 204 | ||
Special Considerations for Abdominal Burkitt Lymphoma | 204 | ||
Post Operation | 205 | ||
Complications | 206 | ||
Tips | 206 | ||
Pitfalls | 206 | ||
MINIMALLY INVASIVE SURGERY IN PAEDIATRIC SURGICAL ONCOLOGY | 208 | ||
1. Introduction | 208 | ||
2. Incidence | 208 | ||
3. Principles of Surgical Resection | 208 | ||
4. Principles of MIS | 209 | ||
5. MIS Approach to Renal Tumours in Children | 209 | ||
6. MIS Approach to Adrenal Tumours in Children | 211 | ||
7. MIS Approach to Gonadal Tumours in Children | 211 | ||
8. MIS Approach to Pancreatic Tumours in Children | 212 | ||
9. MIS Approach to Hepatic Tumours in Children | 213 | ||
10. Minimally Invasive Fertility Preserving Procedures in Children | 213 | ||
11. MIS Approach to Thoracic Tumours in Children | 214 | ||
12. Upcoming Technologies | 214 | ||
Surgical Emergencies and Complications in Paediatric Oncology | 218 | ||
Classification of Commonly Encountered Surgical Emergencies: | 218 | ||
Emergencies Related to Chemotherapy: Part 1 | 218 | ||
Emergencies Related to Tumour Bulk or Mass Effect: Part 2 | 218 | ||
Emergency Access Procedures: Part 3 | 218 | ||
Surgical Biopsies in the Management of BMT Patients: Part 4 | 218 | ||
Emergencies Related to Chemotherapy | 219 | ||
Introduction | 219 | ||
Neutropenic Colitis (Typhlitis) | 219 | ||
Pancreatitis | 224 | ||
Cholelithiasis and Cholecystitis | 225 | ||
Gastrointestinal Haemorrhage | 225 | ||
Anorectal Complications | 226 | ||
Haemorrhagic Cystitis | 227 | ||
Invasive Fungal Infections (Invasive Aspergillosis) | 228 | ||
Extremities | 229 | ||
Emergencies Related to Tumour Bulk | 232 | ||
Bowel Obstruction | 232 | ||
Bowel Gangrene and Perforation | 233 | ||
Intussusception | 235 | ||
Ovarian Tumour Torsion | 237 | ||
Rupture of Renal and Liver Tumours as Emergencies | 239 | ||
Haemoperitoneum | 240 | ||
Urinary Tract Obstruction | 240 | ||
Spinal Cord Compression | 242 | ||
Ventilatory Compromise | 244 | ||
Take Home Messages | 244 | ||
Emergency Access Procedures: | 248 | ||
Tube or Pigtail Thoracostomy | 248 | ||
Central Venous Line Complications | 249 | ||
Insertion of Dialysis Catheter | 250 | ||
Vascular Access | 252 | ||
Tracheostomy Insertion in Certain Emergency Situations | 252 | ||
Take Home Messages | 253 | ||
Surgical Biopsies in the Management of BMT Patients | 256 | ||
FERTILITY PRESERVATION IN CHILDREN | 258 | ||
Epidemiology | 258 | ||
Induced Infertility Mechanisms | 258 | ||
Preoperative Workup | 258 | ||
FERTILITY PRESERVATION IN GIRLS | 259 | ||
Ovarian and Genital Tract Sparing Surgery | 259 | ||
Ovarian Transposition (Oophoropexy) | 260 | ||
Uterine Transposition | 260 | ||
Ovarian Tissue Cryopreservation | 261 | ||
FERTILITY PRESERVATION IN BOYS | 261 | ||
Testicular Sparing Surgery | 261 | ||
Testicular Shielding | 262 | ||
Testicular Transposition | 262 | ||
Semen/Testicular Cryopreservation | 262 | ||
CONCLUSION | 263 | ||
PAEDIATRIC SURGICAL ONCOLOGY AND PALLIATIVE CARE | 267 |